Surging Tamiflu sales boost Chugai's third quarter
27 October 2009
Ian Haydock
Please Login to read the full article.
27 October 2009
Ian Haydock
ian.haydock@informa.com
Tamiflu (oseltamivir) sales of ¥55.8 billion ($607.8 million) in the nine months to September 30th boosted overall sales at Chugai, Roche's Japanese subsidiary, by 35% to ¥303.4 billion over the same period.
Sales of the neuraminidase inhibitor surged from just ¥1.7 billion in...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
